))
Red Beard Ventures Summit 2024 | Trends & innovations in Biotech
Manage episode 402635977 series 3532365
Content provided by Red Beard Ventures. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Red Beard Ventures or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Drew Austin welcomes two experts in the Biotech field to discuss discoveries in psychedelics, cancer treatment, and more. Peter Weijmarshausen, CEO/Co-founder of Humane Genomics and Sam Clark, Founder/CEO of Terran Biosciences highlight how biotech is offering amazing opportunities for investments in scientific innovation.
Participating Panelists:
- Drew Austin, Managing Partner, Red Beard Ventures
- Peter Weijmarshausen, CEO/Co-founder, Humane Genomics
- Sam Clark, Founder/CEO, Terran Biosciences
Main Topics:
- Terran Bioscience developing prescription psychedelic therapies for mental health.
- Human Genomics' revolutionary approach to using synthetic biology to target and eliminate cancer cells.
- The challenges of scientific innovation.
- Finding opportunities for capital deployment in biotech
- Developing affordable treatments for all - making healthcare accessible
Red Beard Ventures: https://redbeard.ventures/
Angel List Syndicate: https://venture.angellist.com/red-beard-ventures-drew-austin/syndicate?utm_campaign=syndicate_direct_link
Red Beard Radio is Sponsored by Alto. Alto makes it easy for individuals to invest in alternative assets with their retirement funds through a self-directed IRA. Access private deals on Alto Marketplace, their new platform for accredited investors: https://www.altoira.com/marketplace
X: @RedBeardVC
Watch the show on YouTube: https://www.youtube.com/channel/UCY-DGmpg2v2rEcXEjn8hJlw
44 episodes
Share
